Skip to main content

ATROPINE

Tracking # 20-809697

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

ATROPINE OR ATROPINE SULFATE CARRIES FDA INDICATIONS FOR ANTI-SIALAGOGUE/ANTI-VAGAL EFFECT, ORGANOPHOSPHATE/MUSCARINIC POISONING, AND BRADYCARDIA. ATROPINE ACTS AS A COMPETITIVE, REVERSIBLE ANTAGONIST OF MUSCARINIC RECEPTORS: AN ANTICHOLINERGIC DRUG. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, SAFE ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, TOXICOLOGY, AND MONITORING OF ATROPINE.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Midwife

1.25h Practice-Focused Continuing Education

Certified Nurse Practitioner

1.25h Practice-Focused Continuing Education

Certified Registered Nurse Anesthetist

1.25h Practice-Focused Continuing Education

Clinical Nurse Specialist

1.25h Practice-Focused Continuing Education

Licensed Practical Nurse

1.25h Practice-Focused Continuing Education

Licensed Psychiatric Technician Nurse

1.25h Practice-Focused Continuing Education

Registered Nurse

1.25h Practice-Focused Continuing Education

Registered Nurse Practitioner

1.25h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Licensed Practical Nurse

1.2h Licensed Practical Nurse - Continuing Education

Registered Nurse

1.2h Pharmacology Component

Georgia Board of Nursing

Licensed Practical Nurse

1.25h General

Registered Professional Nurse

1.25h General

South Carolina Board of Nursing

Advanced Practice Registered Nurse

1.25h Pharmacotherapeutics

Licensed Practical Nurse

1.25h Pharmacotherapeutics

Registered Nurse

1.25h Pharmacotherapeutics

West Virginia Board of Registered Nurses

Advanced Practice Registered Nurse

1.25h Relating to professional nursing practice